Trade DiaMedica Therapeutics Inc. - DMAC CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0408 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023374% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001151% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 3.8496 |
| Open | 3.6896 |
| 1-Year Change | 47.99% |
| Day's Range | 3.6896 - 4.0296 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 23, 2025 | 3.9196 | 0.3600 | 10.11% | 3.5596 | 4.0396 | 3.5596 |
| Apr 22, 2025 | 3.8496 | 0.4800 | 14.25% | 3.3696 | 3.8596 | 3.3696 |
| Apr 21, 2025 | 3.4896 | 0.0700 | 2.05% | 3.4196 | 3.5096 | 3.2796 |
| Apr 17, 2025 | 3.4996 | 0.1700 | 5.11% | 3.3296 | 3.5396 | 3.3296 |
| Apr 16, 2025 | 3.4096 | 0.0700 | 2.10% | 3.3396 | 3.4896 | 3.1996 |
| Apr 15, 2025 | 3.4996 | 0.0000 | 0.00% | 3.4996 | 3.5896 | 3.4696 |
| Apr 14, 2025 | 3.5096 | -0.0100 | -0.28% | 3.5196 | 3.6896 | 3.4796 |
| Apr 11, 2025 | 3.4596 | 0.0700 | 2.07% | 3.3896 | 3.5796 | 3.3796 |
| Apr 10, 2025 | 3.4696 | -0.1300 | -3.61% | 3.5996 | 3.6396 | 3.3896 |
| Apr 9, 2025 | 3.7096 | 0.4600 | 14.16% | 3.2496 | 3.7196 | 3.2196 |
| Apr 8, 2025 | 3.3096 | -0.0400 | -1.19% | 3.3496 | 3.5896 | 3.2896 |
| Apr 7, 2025 | 3.4696 | 0.0500 | 1.46% | 3.4196 | 3.5596 | 3.1396 |
| Apr 4, 2025 | 3.4796 | 0.0300 | 0.87% | 3.4496 | 3.5496 | 3.2996 |
| Apr 3, 2025 | 3.6396 | -0.1400 | -3.70% | 3.7796 | 3.7796 | 3.4896 |
| Apr 2, 2025 | 3.9496 | 0.1600 | 4.22% | 3.7896 | 4.1896 | 3.5896 |
| Apr 1, 2025 | 3.7096 | 0.0900 | 2.49% | 3.6196 | 3.8996 | 3.4896 |
| Mar 31, 2025 | 3.7596 | 0.0700 | 1.90% | 3.6896 | 3.7896 | 3.5396 |
| Mar 28, 2025 | 3.7896 | -0.3100 | -7.56% | 4.0996 | 4.0996 | 3.7496 |
| Mar 27, 2025 | 4.1196 | -0.2300 | -5.29% | 4.3496 | 4.3896 | 4.0896 |
| Mar 26, 2025 | 4.0596 | -0.4300 | -9.58% | 4.4896 | 4.4996 | 4.0596 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
DiaMedica Therapeutics Inc. Company profile
About DiaMedica Therapeutics Inc
DiaMedica Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing treatments for neurological and kidney diseases, such as acute ischemic stroke (AIS) and chronic kidney disease (CKD). The Company's lead product DM199 mimics the behavior of naturally occurring human KLK1 proteins to preserve and restore circulation to stroke-damaged tissue and improve overall kidney function. KLK1 is a serine protease, or protein, produced primarily in the kidneys, pancreas and salivary glands. DM199 therapy has the potential to improve circulation and overall function of critical systems, as well as reduce inflammation and oxidative stress. The Company also has other product pipelines for IgA Nephropathy and African Americans with CKD.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, DiaMedica Therapeutics Inc revenues was not reported. Net loss increased 11% to $13.6M. Higher net loss reflects General and administrative - Balancing increase of 23% to $3.8M (expense), Research and development - Balancing increase of 7% to $8.3M (expense), Governmental assistance research incen decrease from $205K (income) to $0K.
| Industry: | Bio Therapeutic Drugs |
301 Carlson Parkway
Suite 210
MINNEAPOLIS
MINNESOTA 55305
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com